Text Size

Atropine Ophthalmic Solution to Reduce Myopia Progression in Pediatric Subjects: The Randomized, Double-Blind Multicenter Phase II APPLE Study

Chia A, Ngo C, Choudry N, Yamakawa Y, Tan D

  • 2023
  • Asia Pac J Ophthalmol (Phila)
View publication
  • Therapeutic Area

    Back of the eye (BOTE)

  • Categories

    Clinical development

  • Affiliations

    Singapore National Eye Centre, Singapore, Singapore; Department of Ophthalmology, National University Hospital, Singapore, Singapore; Santen Canada Inc., Toronto, ON, Canada; Santen Pharmaceuticals Co. Ltd, Osaka, Japan; Eye and Retina Surgeons, Camden Medical Center, Singapore, Singapore

Related Publications

Efficacy of lutein supplements on macular pigment optical density in highly myopic individuals: A randomized controlled trial

Yoshida T.; Takagi Y.; Igarashi-Yokoi T.; Ohno-Matsui K.

Electrical, Electromagnetic, Ultrasound Wave Therapies, and Electronic Implants for Neuronal Rejuvenation, Neuroprotection, Axonal Regeneration, and IOP Reduction

Sharif, N.A.

Neuroprotection in neurodegenerations of the brain and eye: Lessons from the past and directions for the future

Levin, L .A.; Patrick, C.; Choudry, N.B.; Sharif, N.A.; Goldberg, J.L.

Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022